Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus”

1,661 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,661 results

Post-approval studies (Phase 4)Looking for participantsNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Not applicableWithdrawnNCT00908986
What this trial is testing

Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

Who this might be right for
Lupus Nephritis
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableUnknownNCT06379646
What this trial is testing

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT02472795
What this trial is testing

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Viatris Innovation GmbH 105
Very early researchNot Yet RecruitingNCT07266337
What this trial is testing

CD19/BCMA CAR-T for SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd. 24
Early research (Phase 1)Study completedNCT04136145
What this trial is testing

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 36
Large-scale testing (Phase 3)Study completedNCT05326841
What this trial is testing

Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .

Who this might be right for
Lupus Erythematosus, SystemicCholecalciferol SupplementationDisease Activity+1 more
Dr Cipto Mangunkusumo General Hospital 60
Not applicableUnknownNCT05632029
What this trial is testing

Laser Acupuncture in Egyptian Systemic Lupus Females With Insulin Resistance

Who this might be right for
Systemic Lupus ErythematosusPreDiabetes
Cairo University 64
Early research (Phase 1)WithdrawnNCT06411639
What this trial is testing

Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

Who this might be right for
Sjogren DiseaseSystemic Lupus Erythematosus
Novartis Pharmaceuticals
Very early researchNot Yet RecruitingNCT06886919
What this trial is testing

Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Difficult to Treat Systemic Lupus Erythematosus
Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Not applicableWithdrawnNCT04369495
What this trial is testing

BAFF Levels and Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Universidad de Antioquia
Not applicableNot Yet RecruitingNCT07183007
What this trial is testing

Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Universitas Indonesia 100
Large-scale testing (Phase 3)UnknownNCT04275193
What this trial is testing

The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Shanghai University of Traditional Chinese Medicine 118
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Not applicableLooking for participantsNCT01510067
What this trial is testing

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 700
Next Page